SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
992.00    44.00 (4.64%)
Bid:
972.00
Ask:
988.00
Spread: 16.00 (1.646%)
Market Cap: £271.52m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

US Facilities Update

24 Mar 2020 07:00

RNS Number : 2917H
Gooch & Housego PLC
24 March 2020
 

For immediate release

24 March 2020

 

 

 

Gooch & Housego PLC

("G&H" or the "Group")

 

US Facilities Update

 

 

 

Gooch & Housego PLC (AIM:GHH), the specialist manufacturer of optical components and systems, announces that as a result of COVID-19 related legal orders issued in the States of Ohio and California the Company's facility in Cleveland, Ohio is now closed for a temporary period; this is in addition to its Fremont, California facility, whose temporary closure was announced on 17 March 2020.

 

During this period staff from Cleveland and Fremont facilities who are able to homework will continue to do so. Work will continue on essential maintenance, inventory management and supplying the small number of customers that are within the exempt sectors.

 

The legal order issued by the State of Ohio is effective through 6 April 2020, the order issued by the State of California is effective until further notice and we are awaiting further details on similar stay at home orders in Maryland and Massachusetts.

 

The Group's Moorpark, California; Baltimore, Maryland and Boston, Massachusetts facilties are not affected by the State of California, Maryland or Massachusetts orders in the same way as they operate substantially within an exempt sector.

 

The Group believes that it is likely that a similar order maybe issued in the coming days in the State of New Hampshire where our other US facility is located. G&H anticipates that the impact of such an order on the Group's operations in Keene, New Hampshire would be limited given a significant proportion of the products and services provided by the facility are expected to be exempt from the scope of the order.

 

It is difficult to provide financial guidance at the current time. Nevertheless the effect of these orders will be to shift the balance of revenue generated by the Company to an increased H2 weighting or, depending upon the duration of the situation, potentially in to the Group's next financial year, which would lead to a reduction in our previous estimates for the current year's performance.

 

G&H remains financially secure and well placed to re-establish profitable growth when normal conditions return.

 

 

Further updates will be provided as and when appropriate.

 

 

 

For further information contact: -

 

Mark Webster/Chris Jewell

Gooch & Housego PLC

01460 256440

Mark Court /Charlotte Slater

Buchanan

020 7466 5000

Chris Baird/ Patrick Robb/

David Anderson

Investec Bank plc

020 7597 5970

 

 

 

 

 

 

 

 

Notes to editors

 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDJJMLTMTATBRM
Date   Source Headline
3rd Dec 20137:00 amRNSPreliminary Results
26th Nov 20137:00 amRNSAcquisition of Constelex Technology Enablers Ltd
1st Nov 20137:00 amRNSNotification of Preliminary Results
29th Oct 201312:06 pmRNSHolding(s) in Company
15th Oct 201310:17 amRNSHolding(s) in Company
15th Oct 20137:00 amRNSAcquisition of Spanoptic Limited
8th Oct 201311:21 amRNSHolding(s) in Company
7th Oct 20137:00 amRNSFull-Year Trading Update
1st Oct 201311:52 amRNSHolding(s) in Company
18th Sep 20137:00 amRNSCapital Markets Day
9th Sep 20132:38 pmRNSHolding(s) in Company
25th Jul 20135:54 pmRNSHolding(s) in Company
25th Jul 20135:52 pmRNSHolding(s) in Company
12th Jul 20133:12 pmRNSDirector/PDMR Shareholding
12th Jul 20133:11 pmRNSDirector/PDMR Shareholding
12th Jul 20133:09 pmRNSDirector/PDMR Shareholding
12th Jul 20133:07 pmRNSDirector/PDMR Shareholding
12th Jul 20133:05 pmRNSDirector/PDMR Shareholding
11th Jun 20137:00 amRNSSales and Marketing drive
11th Jun 20137:00 amRNSInterim Report
9th May 20137:00 amRNSNotification of Interim Results
10th Apr 20137:00 amRNSNew Long Term Incentive Plan and grant of Awards
8th Apr 20137:00 amRNSHalf Year Trading Update
19th Mar 201310:44 amRNSAnnual Report and Accounts
15th Mar 201310:50 amRNSHolding(s) in Company
1st Mar 20134:09 pmRNSDirector/PDMR Shareholding
1st Mar 20134:05 pmRNSDirector/PDMR Shareholding
1st Mar 20134:03 pmRNSDirector/PDMR Shareholding
1st Mar 20134:01 pmRNSDirector/PDMR Shareholding
28th Feb 20137:00 amRNSResults of Annual General Meeting
27th Feb 201311:24 amRNSAIM Disclosure Update
27th Feb 20137:00 amRNSTrading Update
4th Feb 20133:00 pmRNSAdditional Listing
18th Jan 20132:12 pmRNSDirector/PDMR Shareholding
18th Jan 20132:11 pmRNSDirector/PDMR Shareholding
18th Jan 20132:09 pmRNSDirector/PDMR Shareholding
10th Jan 20133:00 pmRNSAdditional Listing
7th Jan 20137:00 amRNSValue Creation Plan Crystallises
13th Dec 20124:43 pmRNSHolding(s) in Company
27th Nov 20127:00 amRNSPreliminary Results
23rd Oct 20129:34 amRNSHolding(s) in Company
15th Oct 201211:02 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSDirector change
4th Oct 20127:00 amRNSFull-Year Trading Update
25th Sep 20129:53 amRNSHolding(s) in Company
24th Sep 20122:09 pmRNSAdditional Listing
19th Sep 20128:47 amRNSAdditional Listing
19th Sep 20128:45 amRNSDirector/PDMR Shareholding
4th Sep 20122:14 pmRNSHolding(s) in Company
4th Sep 201210:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.